Conmed (CNMD) EPS (Basic) (2010 - 2026)

Conmed has reported EPS (Basic) for 17 years, with the latest figure at $0.45 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Basic) rose 136.84% year-over-year to $0.45; the trailing twelve-month figure through Mar 2026 stood at $1.77 (down 53.91% YoY), and the FY2025 full-year result was $1.52, down 64.57% from the prior year.
• EPS (Basic) for Q1 2026 stood at $0.45, down from $0.54 in the prior quarter.
• The five-year high for EPS (Basic) was $1.59 in Q3 2024, with the low at -$5.65 in Q2 2022.
• Historically, EPS (Basic) has averaged $0.33 across 5 years, with a median of $0.54 in 2025.
• Annual changes were most pronounced in 2022 — EPS (Basic) plunged 1328.26% — and 2024, when it jumped 966.67%.
• Conmed's EPS (Basic) stood at $0.91 in 2022, then rose by 18.68% to $1.08 in 2023, then rose by 0.93% to $1.09 in 2024, then plunged by 50.46% to $0.54 in 2025, then declined by 16.67% to $0.45 in 2026.
• The last three EPS (Basic) figures came in at $0.45 (Q1 2026), $0.54 (Q4 2025), and $0.09 (Q3 2025), per Business Quant data.